Chronic Obstructive Pulmonary Disease
Showing NaN - NaN of 59
COPD Trial in Canada, United States (Aclidinium Bromide 200 µg, Aclidinium Bromide 400 µg)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium Bromide 200 µg
- Aclidinium Bromide 400 µg
-
Birmingham, Alabama
- +112 more
Mar 9, 2017
COPD, COPD Trial in Germany (QVA149, Tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- COPD
-
Ibbenbüren, Rheinland Pfalz, Germany
- +17 more
Mar 14, 2017
COPD Trial in Worldwide (carmoterol (CHF 4226), salmeterol, )
Completed
- Chronic Obstructive Pulmonary Disease
- carmoterol (CHF 4226)
- +2 more
-
Jonesboro, Arkansas
- +49 more
Apr 7, 2017
Cachexia, COPD, Chronic Heart Failure Trial in Germany, Poland (oral nutrition supplement, food for special medical purposes)
Completed
- Cachexia
- +2 more
- oral nutrition supplement, food for special medical purposes
-
Berlin, Germany
- +3 more
Jan 30, 2017
COPD Trial in Canada, United States (Aclidinium bromide)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium bromide
-
Birmingham, Alabama
- +82 more
Nov 16, 2016
COPD Trial in Canada, United States (Aclidinium bromide, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Aclidinium bromide
- Placebo
-
Birmingham, Alabama
- +111 more
Nov 16, 2016
COPD Trial in Worldwide (Roflumilast, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Roflumilast
- Placebo
-
Box Hill, Australia
- +179 more
Oct 31, 2016
COPD Trial in Germany (QVA149, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- QVA149
- Placebo
-
Koblenz, NRW, Germany
- +29 more
Mar 7, 2016
COPD Trial in Germany (Indacaterol, Tiotropium, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Indacaterol
- +2 more
-
Aschaffenburg, Germany
- +20 more
Feb 16, 2016
COPD Trial in Germany (NVA237, Tiotropium, Placebo to NVA237)
Completed
- Chronic Obstructive Pulmonary Disease
- NVA237
- +4 more
-
Berlin, Germany
- +13 more
Dec 19, 2014
COPD Trial in Worldwide (NVA237, Tiotropium, Placebo to tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- NVA237
- +4 more
-
Toronto, Ontario, Canada
- +75 more
Apr 22, 2014
COPD Trial in Worldwide (QVA149, Tiotropium, Placebo to QVA149)
Completed
- Chronic Obstructive Pulmonary Disease
- QVA149
- +4 more
-
Bruxelles, Belgium
- +42 more
Nov 5, 2013
COPD Trial in Worldwide (QVA149, NVA237, tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- QVA149
- +3 more
-
Birmingham, Alabama
- +344 more
Oct 29, 2013
Spiriva in Chronic Obstructive Pulmonary Disease
Completed
- Chronic Obstructive Pulmonary Disease
-
Amberg, Germany
- +176 more
Nov 27, 2013
COPD Trial in Worldwide (Indacaterol 150 µg, Tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- Indacaterol 150 µg
- Tiotropium
-
Capital Federal, Buenos Aires, Argentina
- +423 more
Sep 16, 2013
COPD Trial in Austria, Germany (QVA149, fluticasone/salmeterol)
Withdrawn
- Chronic Obstructive Pulmonary Disease
-
Feldkirch, Austria
- +28 more
Nov 8, 2013
COPD Trial in United States (Arformoterol, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- Arformoterol
- Placebo
-
Birmingham, Alabama
- +72 more
Sep 12, 2013
COPD Trial in Germany, Switzerland (budesonide/formoterol Turbuhaler 320/9µg, formoterol Turbuhaler 9µg, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- budesonide/formoterol Turbuhaler 320/9µg
- +2 more
-
Berlin, Germany
- +8 more
Jul 27, 2012
COPD Trial in Worldwide (Glycopyrronium bromide, Placebo to glycopyrronium bromide, Tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- Glycopyrronium bromide
- +2 more
-
Birmingham, Alabama
- +138 more
Aug 9, 2012
COPD Trial in Worldwide (AZD9668, AZD9668 Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- AZD9668
- AZD9668 Placebo
-
Fullerton, California
- +104 more
Jun 19, 2012
COPD Trial in Worldwide (NVA237, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- NVA237
- Placebo
-
Spartanburg, South Carolina
- +9 more
Apr 10, 2012
Emphysema, COPD Trial in Worldwide (BTVA System)
Completed
- Emphysema
- Chronic Obstructive Pulmonary Disease
- BTVA System
-
Chermside, Queensland, Australia
- +9 more
Feb 21, 2012
COPD Trial in Worldwide (Indacaterol, Salmeterol/fluticasone (50/500 µg), Salbutamol (200 µg))
Completed
- Chronic Obstructive Pulmonary Disease
- Indacaterol
- +5 more
-
Tamarac, Florida
- +16 more
Sep 7, 2011